91
Participants
Start Date
April 30, 2015
Primary Completion Date
June 30, 2019
Study Completion Date
June 30, 2019
Apixaban
Warfarin
Tampa General Hospital, Tampa
University of South Florida, Tampa
Bayfront Health St Petersburg, St. Petersburg
University of Louisville, Louisville
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
University of South Florida
OTHER